Simply in the past decade, researchers have recognized the huge function that the microbes living inside and on us play in our health. The human microbiome, and particularly the gut microbiome, has been connected to multiple chronic illness, consisting of diabetes. An unbalanced microbiome structure has actually been found in patients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy people. Length.
Some business are establishing diabetes treatments targeting the microbiome. The French Valviotis is currently performing preclinical screening of a drug intended at increasing the microbiome variety as a treatment for type 2 diabetes. Although appealing, the microbiome field is very young and its complexity makes it challenging to develop causation after finding correlation.
That world may not be so far away, as many business are developing non-invasive approaches to substitute finger pricking. Length. Stability Applications has developed a device called GlucoTrack that can determine glucose utilizing electromagnetic waves and is already available in Europe. Comparable innovations are popping up, with GlucoSense in London using laser light to determine sugar levels and MediWise using radio waves.
The GlucoWise sensing unit prototypePatches are also ending up being a popular type of determining blood glucose without needles, such as FreeStyle Libre, an inch-wide patch that can be used for up to 2 weeks. At the University of Bath, researchers are establishing a graphene patch that could offer greater precision by determining sugar levels separately in numerous hair roots – Length.
Meanwhile, Senseonic and Roche are dealing with a device that is implanted under the skin. Length. Still, non-invasive options to measure blood sugar level typically deal with problems concerning accuracy. The famous glucose-measuring contact lens that Google revealed in 2014 was dismissed as “technically infeasible” and further advancements will be required to reach the degree of accuracy of finger-pricking approaches.
Scientists are already hypothesizing about microchips that can detect diabetes type 1 prior to the signs appear or nanorobots taking a trip in the blood stream while they determine glucose and provide insulin – Length.”There’s little fiction left in this. I strongly think that microrobotics will come and will be part of our drug shipment within the next 10 years,” said Tomas Landh, Director of Strategy and Innovation Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will certainly make a big distinction in the lives of millions of individuals worldwide.